other material
confidence high
sentiment positive
materiality 0.65
Evofem raises $2.28M via private placement of Series F-1 Preferred Stock to Aditxt
Evofem Biosciences, Inc.
- Aditxt purchased 2,280 Series F-1 Preferred Stock shares for $2,280,000 in a private placement.
- Shares are convertible into common stock; company granted registration rights for resale.
- Private placement closed Oct 28, 2024; exempt from registration under Section 4(a)(2) of Securities Act.
- Part of consideration for A&R Merger Agreement with Aditxt, as previously disclosed.
- Company filed Registration Rights Agreement to register conversion shares within 300 days.